Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡